More on ADIL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-425.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Adial Pharmaceuticals (NQ:ADIL)
Delayed: 3.49 +0.35 (11.15%)
Prev. Close $3.14  
Open$3.07 
52 Wk High$ 
52 Wk Low$ 
Day High$3.66 
Day Low$3.07 
P/E N/A  
EPS$ 
Volume56,446 


Oct 16, 2026 05:17 PM Form DEFA14A ADIAL PHARMACEUTICALS,
Oct 16, 2026 05:15 PM Form 8-K ADIAL PHARMACEUTICALS, For: Oct 15
Oct 16, 2026 07:01 AM Adial Pharmaceuticals names former Dermavant CSO as chief scientist
Oct 16, 2026 07:00 AM Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis
Oct 5, 2026 06:02 AM Form DEFA14A ADIAL PHARMACEUTICALS,
Oct 2, 2026 04:16 PM Form 8-K ADIAL PHARMACEUTICALS, For: Oct 01
Sep 30, 2026 05:46 PM Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Sep 21, 2026 07:26 PM Form 4 ADIAL PHARMACEUTICALS, For: Sep 17 Filed by: Young Wendy B.
Sep 18, 2026 05:18 PM Form DEFA14A ADIAL PHARMACEUTICALS,
Sep 18, 2026 04:27 PM Form 8-K ADIAL PHARMACEUTICALS, For: Sep 17
View All Articles

Entities mentioned with ADIL

View All Entities